A Ph⁺ Acute Myeloid Leukaemia Expressing Both CML-Type and ALL-Type BCR/ABL mRNA Transcripts

References

• Le Beau M. M., Rowley J. D. Recurring chromosomal abnormalities in leukaemia and lymphoma. Cancer Surv. 1984; 3: 371–394
   Google Scholar
• Shtivelman E., Lifshitz B., Gale R. P., Canaani E. Fused transcript of abl, bcr genes in chronic myelogenous leukaemia. Nature 1985; 315: 550–554
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Stam K., Groffen J. Structural organisation of the bcr gene and its role in the Ph' translocation. Nature 1985; 315: 758–761
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Knoppel E., Groffen J. The first BCR gene intron contains breakpoints in Philadelphia chromosome positive leukaemia. Nucleic Acid Research 1988; 16: 10069–10081
   PubMed Web of Science ®Google Scholar
• Fainstein E., Marcelle C., Rosner A., Canaani E., Gale R. P., Dreazen O., Smith S. D., Croce C. M. A new fused transcript in Philadelphia chromosome positive acute leukaemia. Nature 1987; 330: 386–388
   PubMed Web of Science ®Google Scholar
• Westbrook C. A., Rubin C. M., Carrino J. J., Le Beau M. M., Bernards A., Rowley J. D. Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis. Blood 1988; 71: 697–702
   PubMed Web of Science ®Google Scholar
• Maru Y., Witte O. N. The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Cell 1991; 67: 459–468
   PubMed Web of Science ®Google Scholar
• Lange W., Snyder D. S., Castro R., Rossi J. J., Blume K. G. Detection by enzymatic amplification of bcr-abl mRNA in peripheral blood and bone marrow cells of patients with chronic myeloid leukaemia. Blood 1989; 73: 1735–1741
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Talpaz M., Dhingra K., Estey E., Keating M. J., Ku S., Trujillo J., Huh Y., Stass S. A., Kurzrock R. Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukaemia. Blood 1991; 78: 2411–2418
   PubMed Web of Science ®Google Scholar
• Price C. M., Rassool F., Shivji M. K. K., Gow J., Tew C. J., Haworth C., Goldman J. M., Weidemann L. M. Rearrangement of the breakpoint cluster region and expression of p210 bcr/abl in a “masked” Philadelphia chromosome-positive acute myeloid leukaemia. Blood 1988; 72: 1829–1832
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Shtalrid M., Talpaz M., Kloetzer W. S., Gutterman J. U. Expression of c-abl in Philadelphia-positive acute myelogenous leukaemia. Blood 1987; 70: 1584–1588
   PubMed Web of Science ®Google Scholar
• Lee M-S., Le Maistre A., Kantarjian H. M., Talpaz M., Freireich E. J., Trujillo J., Stass S. A. Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukaemia by polymerase chain reaction. Blood 1989; 73: 2165–2170
   PubMed Web of Science ®Google Scholar
• Webber L., Garson O. M. Fluorodeoxyuridine synchronisation of bone marrow cultures. Cancer Genet. Cytogenet. 1983; 8: 123–132
   PubMed Web of Science ®Google Scholar
• Catovsky D. A. Blood-cell cytochemistry and supplementary techniques: The myeloperoxidase reaction. Practical Haematology, J. V. Dacie, S. M. Lewis. Churchill Livingstone Publishers, London 1984; 84–86
   Google Scholar
• Ma D. D. F., Scurr R. D., Davey R. A., Mackertich S. M., Harman D. H., Dowden D., Isbister J. P., Bell D. R. Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia. Lancet 1987; 17: 135–137
   Google Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Brisco M. J., Tan L. W., Osborne A. M., Morley A. A. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br. J. Haematol. 1990; 75: 163–167
   PubMed Web of Science ®Google Scholar
• Jandl J. H. Acute myelogenous leukaemia. Blood: Textbook of Haematology. Little, Brown and Company, Boston 1987; 629–670
   Google Scholar
• Jandl J. H. Chronic myeloproliferative syndromes. Blood- Textbook of Haematology. Little, Brown and Company, Boston 1987; 671–725
   Google Scholar
• Sobol R. E., Mick R., Royston I., Davey F. R., Ellison R. R., Newman R., Cuttner J., Griffen J. D., Collins H., Nelson D. A., Bloomfield C. D. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukaemia. N. Engl. J. Med. 1987; 316: 1111–1117
   PubMed Web of Science ®Google Scholar
• Rowley J. D., Golomb H. M., Vardiman J. W. Nonrandom chromosomal abnormalities in acute leukaemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood 1981; 58: 759–767
   PubMed Web of Science ®Google Scholar
• Gagnon G. A., Childs C. C., Le Maistre A., Keating M., Cork A., Trujillo J. M., Nellis K., Freireich E., Stass S. A. Molecular heterogeneity in acute leukaemia lineage switch. Blood 1989; 74: 2088–2095
   PubMed Web of Science ®Google Scholar
• Maurer J., Janssen J. W. G., Thiel E., van Denderen J., Ludwig W-D., Aydemir U., Heinze B., Fonatsch C., Harbott J., Reiter A., Riehm H., Hoelzer D., Bartram C. R. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991; 337: 1055–1058
   PubMed Web of Science ®Google Scholar
• Hooberman A. L., Carrino J. J., Leibowitz D., Rowley J. D., Le Beau M. M., Arlin Z. A., Westbrook C. A. Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukaemia. Proc. Natl. Acad. Sci. USA 1989; 86: 4259–4263
   PubMed Web of Science ®Google Scholar
• Shannon K., Chang S., Morley B., Smith S. D., Kawasaki E., Russo C., Kan Y. W. Simultaneous expression of CML and ALL types of mRNA transcripts in Philadelphia (Ph1) chromosome-positive leukaemia (Abstract). Blood 1988; 72: 225a
   Google Scholar
• van der Plas D. C., Grosveld G., Hagemeijer A. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. Cancer Genet. Cytogenet. 1991; 52: 143–156
   PubMed Web of Science ®Google Scholar